European Geriatric Medicine

, Volume 10, Issue 2, pp 259–265 | Cite as

Geriatric-HIV Medicine: the geriatrician’s role

  • Fátima BrañasEmail author
  • Pablo Ryan
  • Jesús Troya
  • Matilde Sánchez-Conde


The scenario of people living with HIV has dramatically changed, and nowadays older adults with HIV constitute almost half of the HIV population—and the percentage is growing. Frailty and geriatric syndromes have been highly demonstrated among older adults with HIV; therefore, the application of geriatric medicine principles to their approach has become essential. Geriatric-HIV Medicine, specific, collaborative work between HIV specialists and geriatricians, is a young discipline that has the goal of ensuring a global and specific approach to older patients that is focused on function and the continuum of care. The geriatrician’s role adds value to the care of older people living with HIV through Comprehensive Geriatric Assessment for those patients who can benefit but goes beyond the clinical approach and involves generating scientific evidence that impacts and changes the current model of care.


HIV Older adults Geriatric medicine Geriatrician 


Compliance with ethical standards

Conflict of interest

FB has received honoraria for the following: MISP grants from MSD, speaking at symposia organized on behalf of MSD and ViiV Healthcare; developing educational materials for MSD; and board membership from ViiV Healthcare. PR has received honoraria for the following: lectures and advisory boards from AbbVie, Gilead Sciences, Merck Sharp & Dohme, Janssen and ViiV. He has also received a MISP grant from Merck Sharp & Dohme and funding from the CHIME 2018 program from Gilead Sciences and travel grants from Gilead Sciences, Merck Sharp & Dohme and Janssen. JT has received honoraria for the following: lectures from Gilead Sciences, Merck Sharp & Dohme. He has also received travel grants from Gilead Sciences, and Janssen. MSC has received honoraria for the following: speaking at symposia organized on behalf of MSD, ViiV Healthcare and Gilead.

Ethical approval

This article does not contain any studies with human participants or animals performed by any of the authors.

Informed consent

For this type of study formal consent is not required.


  1. 1.
    Bunting E, Rajkumar C, Fisher M (2014) The human immunodeficiency virus and ageing. Age Ageing 43:308–310CrossRefGoogle Scholar
  2. 2.
    HIV and aging. UNAIDS. A special supplement to the UNAIDS report on the global AIDS epidemic 2013.
  3. 3.
    Centers for Disease Control and Prevention (2014) HIV surveillance report, vol 25. http://www.cdcgov/hiv/pdf/library/reports/surveillance/cdc-hiv-surveillancereport-uspdf. Accessed Nov 2015
  4. 4.
    Smit M, Brinkman K, Geerlings S, Smit C, Thyagarajan K, Sighem A et al (2015) Future challenges for clinical care of an ageing population infected with HIV: a modelling study. Lancet Infect Dis 15(7):810–818CrossRefGoogle Scholar
  5. 5.
    Guaraldi G, Orlando G, Zona S, Menozzi M, Carli F, Garlassi E et al (2011) Premature age-related comorbidities among HIV-infected persons compared with the general population. Clin Infect Dis 53(11):1120–1126CrossRefGoogle Scholar
  6. 6.
    Brañas F, Jiménez Z, Sánchez-Conde M, Dronda F, López-Bernaldo De Quirós JC, Pérez-Elías MJ et al (2017) Frailty and physical function in older HIV-infected adults. Age Ageing 14:1–5Google Scholar
  7. 7.
    Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J et al (2001) Frailty in older adults: evidence for a phenotype. J Gerontol Ser A Biol Sci Med Sci 56(3):M146–M156CrossRefGoogle Scholar
  8. 8.
    Bandeen-Roche K, Seplaki CL, Huang J, Buta B, Kalyani RR, Varadhan R et al (2015) Frailty in older adults: a nationally representative profile in the United States. J Gerontol Ser A Biol Sci Med Sci 70(11):1427–1434CrossRefGoogle Scholar
  9. 9.
    Abizanda P, Sanchez-Jurado PM, Romero L, Paterna G, Martinez-Sanchez E, Atienzar-Nunez P (2011) Prevalence of frailty in a Spanish elderly population: the Frailty and Dependence in Albacete study. J Am Geriatr Soc 59(7):1356–1359 CrossRefGoogle Scholar
  10. 10.
    Greene M, Covinsky K, Astemborski J, Piggott DA, Brown T, Leng S et al (2014) The relationship of physical performance with HIV disease and mortality. AIDS 28(18):2711–2719CrossRefGoogle Scholar
  11. 11.
    Erlandson KM, Allshouse AA, Jankowski CM, Duong S, Mawhinney S, Kohrt WM et al (2012) Comparison of functional status instruments in HIV-infected adults on effective antiretroviral therapy. HIV Clin Trials 13(6):324–334CrossRefGoogle Scholar
  12. 12.
    Malaspina L, Woods SP, Moore DJ, Depp C, Letendre SL, Jeste D et al (2011) Successful cognitive aging in persons living with HIV infection. J Neurovirol 17(1):110–119CrossRefGoogle Scholar
  13. 13.
    Wallace LM, Ferrara M, Brothers TD, Garlassi S, Kirkland SA, Theou O et al (2017) Lower frailty is associated with successful cognitive aging among older adults with HIV. AIDS Res Hum Retrovir 33(2):157–163CrossRefGoogle Scholar
  14. 14.
    Bing EG, Burnam MA, Longshore D, Fleishman JA, Sherbourne CD, London AS et al (2001) Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States. Arch Gen Psychiatry 58(8):721–728CrossRefGoogle Scholar
  15. 15.
    Dal-Bo MJ, Manoel AL, Filho AO, Silva BQ, Cardoso YS, Cortez J et al (2015) Depressive symptoms and associated factors among people living with HIV/AIDS. J Int Assoc Providers AIDS Care 14(2):136–140CrossRefGoogle Scholar
  16. 16.
    Nanni MG, Caruso R, Mitchell AJ, Meggiolaro E, Grassi L (2015) Depression in HIV infected patients: a review. Curr Psychiatry Rep 17(1):530 CrossRefGoogle Scholar
  17. 17.
    Johnson Shen M, Freeman R, Karpiak S, Brennan-Ing M, Seidel L, Siegler EL (2018) The intersectionality of stigmas among key populations of older adults affected by HIV: a thematic analysis. Clin Gerontol 26:1–13 Google Scholar
  18. 18.
    Shrestha R, Copenhaver M, Bazazi AR, Huedo-Medina TB, Krishnan A, Altice FL (2017) A moderated mediation model of HIV-related stigma, depression, and social support on health-related quality of life among incarcerated malaysian men with HIV and opioid dependence. AIDS Behav 21(4):1059–1069CrossRefGoogle Scholar
  19. 19.
    Centers for Disease Control and Prevention (CDC) (1998) AIDS among persons aged ≥ 50 years—United States, 1991–1996. MMWR Morb Mortal Wkly Rep 47:21–27Google Scholar
  20. 20.
    Jedlovsky V, Fleischman JK (2000) Pneumocystis carinii pneumonia as the first presentation of HIV infection in patients older than fifty. AIDS Patient Care STDs 14(5):247–249CrossRefGoogle Scholar
  21. 21.
    Truax J (2003) HIV infection and aging: a personal journey. J Acquir Immune Defic Syndr 33(Suppl 2):S169–S170CrossRefGoogle Scholar
  22. 22.
    Fowler JP (2003) Aging with HIV: one woman’s story. J Acquir Immune Defic Syndr 33(Suppl 2):S166–S168CrossRefGoogle Scholar
  23. 23.
    Cloud GC, Browne R, Salooja N, McLean KA (2003) Newly diagnosed HIV infection in an octogenarian: the elderly are not ‘immune’. Age Ageing 32(3):353–354CrossRefGoogle Scholar
  24. 24.
    Knodel J, Watkins S, VanLandingham M (2003) AIDS and older persons: an international perspective. J Acquir Immune Defic Syndr 33(Suppl 2):S153–S165CrossRefGoogle Scholar
  25. 25.
    Auerbach JD (2003) HIV/AIDS and aging: interventions for older adults. J Acquir Immune Defic Syndr 33(Suppl 2):S57–S58CrossRefGoogle Scholar
  26. 26.
    Manfredi R (2004) HIV infection and advanced age emerging epidemiological, clinical, and management issues. Ageing Res Rev 3(1):31–54CrossRefGoogle Scholar
  27. 27.
    Grabar S, Weiss L, Costagliola D (2006) HIV infection in older patients in the HAART era. J Antimicrob Chemother 57(1):4–7CrossRefGoogle Scholar
  28. 28.
    Manfredi R, Chiodo F (2000) A case-control study of virological and immunological effects of highly active antiretroviral therapy in HIV-infected patients with advanced age. AIDS 14(10):1475–1477CrossRefGoogle Scholar
  29. 29.
    Knobel H, Guelar A, Valldecillo G, Carmona A, Gonzalez A, Lopez-Colomes JL et al (2001) Response to highly active antiretroviral therapy in HIV-infected patients aged 60 years or older after 24 months follow-up. AIDS 15(12):1591–1593CrossRefGoogle Scholar
  30. 30.
    Wellons MF, Sanders L, Edwards LJ, Bartlett JA, Heald AE, Schmader KE (2002) HIV infection: treatment outcomes in older and younger adults. J Am Geriatr Soc 50(4):603–607CrossRefGoogle Scholar
  31. 31.
    Grimes RM, Otiniano ME, Rodriguez-Barradas MC, Lai D (2002) Clinical experience with human immunodeficiency virus-infected older patients in the era of effective antiretroviral therapy. Clin Infect Dis 34(11):1530–1533CrossRefGoogle Scholar
  32. 32.
    Perez JL, Moore RD (2003) Greater effect of highly active antiretroviral therapy on survival in people aged ≥ 50 years compared with younger people in an urban observational cohort. Clin Infect Dis 36(2):212–218CrossRefGoogle Scholar
  33. 33.
    Grabar S, Kousignian I, Sobel A, Le Bras P, Gasnault J, Enel P et al (2004) Immunologic and clinical responses to highly active antiretroviral therapy over 50 years of age. Results from the French Hospital Database on HIV. AIDS 18(15):2029–2038CrossRefGoogle Scholar
  34. 34.
    Conde M, Lopez-Bernaldo de Quiros JC, Miralles P, Cosin J et al (2008) The eldest of older adults living with HIV: response and adherence to highly active antiretroviral therapy. Am J Med 121(9):820–824CrossRefGoogle Scholar
  35. 35.
    Desquilbet L, Jacobson LP, Fried LP, Phair JP, Jamieson BD, Holloway M et al (2007) HIV-1 infection is associated with an earlier occurrence of a phenotype related to frailty. J Gerontol Ser A Biol Sci Med Sci 62(11):1279–1286CrossRefGoogle Scholar
  36. 36.
    Desquilbet L, Margolick JB, Fried LP, Phair JP, Jamieson BD, Holloway M et al (2009) Relationship between a frailty-related phenotype and progressive deterioration of the immune system in HIV-infected men. J Acquir Immune Defic Syndr 50(3):299–306CrossRefGoogle Scholar
  37. 37.
    Desquilbet L, Jacobson LP, Fried LP, Phair JP, Jamieson BD, Holloway M et al (2011) A frailty-related phenotype before HAART initiation as an independent risk factor for AIDS or death after HAART among HIV-infected men. J Gerontol Ser A Biol Sci Med Sci 66(9):1030–1038CrossRefGoogle Scholar
  38. 38.
    Althoff KN, Jacobson LP, Cranston RD, Detels R, Phair JP, Li X et al (2014) Age, comorbidities, and AIDS predict a frailty phenotype in men who have sex with men. J Gerontol Ser A Biol Sci Med Sci 69(2):189–198CrossRefGoogle Scholar
  39. 39.
    Piggott DA, Muzaale AD, Mehta SH, Brown TT, Patel KV, Leng SX et al (2013) Frailty, HIV infection, and mortality in an aging cohort of injection drug users. PloS One 8(1):e54910CrossRefGoogle Scholar
  40. 40.
    Piggott DA, Varadhan R, Mehta SH, Brown TT, Li H, Walston JD et al (2015) Frailty, inflammation, and mortality among persons aging with HIV infection and injection drug use. J Gerontol Ser A Biol Sci Med Sci 70(12):1542–1547CrossRefGoogle Scholar
  41. 41.
    Piggott DA, Muzaale AD, Varadhan R, Mehta SH, Westergaard RP, Brown TT et al (2017) Frailty and cause-specific hospitalization among persons aging with HIV infection and injection drug use. J Gerontol Ser A Biol Sci Med Sci 72(3):389–394Google Scholar
  42. 42.
    Terzian AS, Holman S, Nathwani N, Robison E, Weber K, Young M et al (2009) Factors associated with preclinical disability and frailty among HIV-infected and HIV-uninfected women in the era of cART. J Womens Health (Larchmt) 18(12):1965–1974CrossRefGoogle Scholar
  43. 43.
    Gustafson DR, Shi Q, Thurn M, Holman S, Minkoff H, Cohen M et al (2016) Frailty and constellations of factors in aging HIV-infected and uninfected women-the women’s interagency HIV study. J Frailty Aging 5(1):43–48Google Scholar
  44. 44.
    Guaraldi G, Brothers TD, Zona S, Stentarelli C, Carli F, Malagoli A et al (2015) A frailty index predicts survival and incident multimorbidity independent of markers of HIV disease severity. AIDS 29(13):1633–1641CrossRefGoogle Scholar
  45. 45.
    Onen NF, Agbebi A, Shacham E, Stamm KE, Onen AR, Overton ET (2009) Frailty among HIV-infected persons in an urban outpatient care setting. J Infect 59(5):346–352CrossRefGoogle Scholar
  46. 46.
    Onen NF, Patel P, Baker J, Conley L, Brooks JT, Bush T et al (2014) Frailty and pre-frailty in a contemporary cohort of HIV-infected adults. J Frailty Aging 3(3):158–165Google Scholar
  47. 47.
    Erlandson KM, Schrack JA, Jankowski CM, Brown TT, Campbell TB (2014) Functional impairment, disability, and frailty in adults aging with HIV-infection. Curr HIV/AIDS Rep 11(3):279–290CrossRefGoogle Scholar
  48. 48.
    Erlandson KM, Wu K, Koletar SL, Kalayjian RC, Ellis RJ, Taiwo B et al (2017) Association between frailty and components of the frailty phenotype with modifiable risk factors and antiretroviral therapy. J Infect Dis 215(6):933–937CrossRefGoogle Scholar
  49. 49.
    Rees HC, Ianas V, McCracken P, Smith S, Georgescu A, Zangeneh T et al (2013) Measuring frailty in HIV-infected individuals. Identification of frail patients is the first step to amelioration and reversal of frailty. J Vis Exp 24(77):50537Google Scholar
  50. 50.
    Ianas V, Berg E, Mohler MJ, Wendel C, Klotz SA (2013) Antiretroviral therapy protects against frailty in HIV-1 infection. J Int Assoc Providers AIDS Care 12(1):62–66CrossRefGoogle Scholar
  51. 51.
    Sandkovsky U, Robertson KR, Meza JL, High RR, Bonasera SJ, Fisher CM et al (2013) Pilot study of younger and older HIV-infected adults using traditional and novel functional assessments. HIV Clin Trials 14(4):165–174CrossRefGoogle Scholar
  52. 52.
    John MD, Greene M, Hessol NA, Zepf R, Parrott AH, Foreman C et al (2016) Geriatric assessments and association with VACS index among HIV-infected older adults in San Francisco. J Acquir Immune Defic Syndr 72(5):534–541Google Scholar
  53. 53.
    Greene M, Covinsky KE, Valcour V, Miao Y, Madamba J, Lampiris H et al (2015) Geriatric syndromes in older HIV-infected adults. J Acquir Immune Defic Syndr 69(2):161–167CrossRefGoogle Scholar
  54. 54.
    Pathai S, Gilbert C, Weiss HA, Cook C, Wood R, Bekker LG et al (2013) Frailty in HIV-infected adults in South Africa. J Acquir Immune Defic Syndr 62(1):43–51CrossRefGoogle Scholar
  55. 55.
    Zamudio-Rodriguez A, Belaunzaran-Zamudio PF, Sierra-Madero JG, Cuellar-Rodriguez J, Crabtree-Ramirez BE, Alcala-Zermeno JL et al (2018) Association between frailty and HIV-associated neurodegenerative disorders among older adults living with HIV. AIDS Res Hum Retrovir 34(5):449–455CrossRefGoogle Scholar
  56. 56.
    Guaraldi G, Malagoli A, Theou O, Brothers TD, Wallace L, Torelli R et al (2017) Correlates of frailty phenotype and frailty index and their associations with clinical outcomes. HIV Med 18(10):764–771CrossRefGoogle Scholar
  57. 57.
    Bregigeon S, Galinier A, Zaegel-Faucher O, Cano CE, Obry V, Laroche H et al (2017) Frailty in HIV infected people: a new risk factor for bone mineral density loss. AIDS 31(11):1573–1577CrossRefGoogle Scholar
  58. 58.
    Effros RB, Fletcher CV, Gebo K, Halter JB, Hazzard WR, Horne FM et al (2008) Aging and infectious diseases: workshop on HIV infection and aging: what is known and future research directions. Clin Infect Dis 47(4):542–553CrossRefGoogle Scholar
  59. 59.
    Tinetti ME, Fried T (2004) The end of the disease era. Am J Med 116(3):179–185CrossRefGoogle Scholar
  60. 60.
    Cesari M, Marzetti E, Canevelli M, Guaraldi G (2017) Geriatric syndromes: how to treat. Virulence 8(5):577–585CrossRefGoogle Scholar
  61. 61.
    World Health Organization (2015) World report on ageing and health. World Health Organization, Geneva, Switzerland.;jsessionid=DB5B11EB24ABAA78905DE1E7CE8DF414?sequence=1
  62. 62.
    Singh HK, Del Carmen T, Freeman R, Glesby MJ, Siegler EL (2017) From one syndrome to many: incorporating geriatric consultation into HIV care. Clin Infect Dis 65(3):501–506CrossRefGoogle Scholar
  63. 63.
    Guaraldi G, Palella FJ Jr (2017) Clinical implications of aging with HIV infection: perspectives and the future medical care agenda. AIDS 31(Suppl 2):S129–S135CrossRefGoogle Scholar
  64. 64.
    Guaraldi G, Cossarizza A (2017) Geriatric-HIV Medicine: a science in its infancy. Virulence 8(5):504–507CrossRefGoogle Scholar
  65. 65.
    Kammerlander C, Roth T, Friedman SM, Suhm N, Luger TJ, Kammerlander-Knauer U et al (2010) Ortho-geriatric service—a literature review comparing different models. Osteoporos Int 21(Suppl 4):S637–S646CrossRefGoogle Scholar
  66. 66.
    Rich MW, Chyun DA, Skolnick AH, Alexander KP, Forman DE, Kitzman DW et al (2016) Knowledge gaps in cardiovascular care of the older adult population: a scientific statement from the American Heart Association, American College of Cardiology, and American Geriatrics Society. Circulation 133(21):2103–2122CrossRefGoogle Scholar
  67. 67.
    Wildiers H, Heeren P, Puts M, Topinkova E, Janssen-Heijnen ML, Extermann M et al (2014) International Society of Geriatric Oncology consensus on geriatric assessment in older patients with cancer. J Clin Oncol 32(24):2595–2603CrossRefGoogle Scholar
  68. 68.
    Leipzig RM, Sauvigne K, Granville LJ, Harper GM, Kirk LM, Levine SA et al (2014) What is a geriatrician? American Geriatrics Society and Association of Directors of Geriatric Academic Programs end-of-training entrustable professional activities for geriatric medicine. J Am Geriatr Soc 62(5):924–929CrossRefGoogle Scholar
  69. 69.
    Siegler EL, Burchett CO, Glesby MJ (2018) Older people with HIV are an essential part of the continuum of HIV care. J Int AIDS Soc 21(10):e25188CrossRefGoogle Scholar
  70. 70.
    Ellis G, Whitehead MA, O’Neill D, Langhorne P, Robinson D (2011) Comprehensive geriatric assessment for older adults admitted to hospital. Cochrane Datab Syst Rev 6(7):CD006211Google Scholar
  71. 71.
    Warren MW (1946) Care of the chronic aged sick. Lancet 1(6406):841–843CrossRefGoogle Scholar
  72. 72.
    Rubenstein LZ, Josephson KR, Wieland GD, English PA, Sayre JA, Kane RL (1984) Effectiveness of a geriatric evaluation unit. A randomized clinical trial. N Engl J Med 311(26):1664–1670CrossRefGoogle Scholar
  73. 73.
    Stuck AE, Siu AL, Wieland GD, Adams J, Rubenstein LZ (1993) Comprehensive geriatric assessment: a meta-analysis of controlled trials. Lancet 342(8878):1032–1036CrossRefGoogle Scholar
  74. 74.
    Parker SG, McLeod A, McCue P, Phelps K, Bardsley M, Roberts HC et al (2017) New horizons in comprehensive geriatric assessment. Age Ageing 46(5):713–721CrossRefGoogle Scholar
  75. 75.
    Abellan van Kan G, Rolland YM, Morley JE, Vellas B (2008) Frailty: toward a clinical definition. J Am Med Directors Assoc 9(2):71–72CrossRefGoogle Scholar
  76. 76.
    Rockwood K, Song X, MacKnight C, Bergman H, Hogan DB, McDowell I et al (2005) A global clinical measure of fitness and frailty in elderly people. CMAJ 173(5):489–495CrossRefGoogle Scholar
  77. 77.
    Harris TG, Rabkin M, El-Sadr WM (2018) Achieving the fourth 90: healthy aging for people living with HIV. AIDS 32(12):1563–1569CrossRefGoogle Scholar

Copyright information

© European Geriatric Medicine Society 2018

Authors and Affiliations

  • Fátima Brañas
    • 1
    Email author
  • Pablo Ryan
    • 2
  • Jesús Troya
    • 2
  • Matilde Sánchez-Conde
    • 3
  1. 1.Geriatrics DepartmentInfanta Leonor University HospitalMadridSpain
  2. 2.HIV Unit, Internal Medicine DepartmentInfanta Leonor University HospitalMadridSpain
  3. 3.Infectious Diseases and HIV DepartmentRamón y Cajal University HospitalMadridSpain

Personalised recommendations